These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 10724055

  • 1. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
    Bakris GL, Weir MR.
    Arch Intern Med; 2000 Mar 13; 160(5):685-93. PubMed ID: 10724055
    [Abstract] [Full Text] [Related]

  • 2. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul 13; 50(7):1297-300. PubMed ID: 12133029
    [Abstract] [Full Text] [Related]

  • 3. Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study.
    Jackevicius CA, Wong J, Aroustamian I, Gee M, Mody FV.
    BMJ Open; 2014 Jul 13; 4(8):e005181. PubMed ID: 25232564
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues.
    Mangrum AJ, Bakris GL.
    Semin Nephrol; 2004 Mar 13; 24(2):168-75. PubMed ID: 15017529
    [Abstract] [Full Text] [Related]

  • 5. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.
    Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D.
    Kidney Int; 2000 Nov 13; 58(5):2084-92. PubMed ID: 11044229
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR, Rahim S, Etherington K, Rokoss ML, Natarajan MK, Velianou JL, Brons S, Mehta SR, CAPTAIN Investigators.
    Am Heart J; 2015 Jul 13; 170(1):110-6. PubMed ID: 26093871
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E, Camerini C, Gaggia P, Zubani R, Cancarini G.
    Am J Nephrol; 2018 Jul 13; 48(2):79-86. PubMed ID: 30071530
    [Abstract] [Full Text] [Related]

  • 12. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H, Nelges C, Täger T, Schwenger V, Cebola R, Schnorbach J, Goode KM, Kazmi S, Katus HA, Cleland JG, Clark AL, Frankenstein L.
    Am Heart J; 2016 Aug 13; 178():28-36. PubMed ID: 27502849
    [Abstract] [Full Text] [Related]

  • 13. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA.
    Cardiovasc Ther; 2012 Jun 13; 30(3):e156-66. PubMed ID: 21883995
    [Abstract] [Full Text] [Related]

  • 14. Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease.
    Oktaviono YH, Kusumawardhani N.
    Acta Med Indones; 2020 Jan 13; 52(1):74-79. PubMed ID: 32291375
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.
    Bhandari S, Ives N, Brettell EA, Valente M, Cockwell P, Topham PS, Cleland JG, Khwaja A, El Nahas M.
    Nephrol Dial Transplant; 2016 Feb 13; 31(2):255-61. PubMed ID: 26429974
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.
    Mitterbauer C, Heinze G, Kainz A, Kramar R, Hörl WH, Oberbauer R.
    Nephrol Dial Transplant; 2008 May 13; 23(5):1742-6. PubMed ID: 18234845
    [Abstract] [Full Text] [Related]

  • 19. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr 13; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 20. Assessment of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker on the split renal function in the patients with primary hypertension.
    Zhang J, Wang M, Sun K, Ding Y.
    Medicine (Baltimore); 2021 May 21; 100(20):e25928. PubMed ID: 34011065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.